Novel Agents and Drug Development Needs in Advanced Clear Cell Renal Cancer

The treatment of metastatic clear cell renal cancer is changing rapidly, with the focus switching from vascular endothelial growth factor-targeted therapies to immune checkpoint inhibitors and novel combinations.03/07/2019
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news